>
Regulatory Brief

An overview of 21 CFR Part 11 regulations for medical device companies

The U.S. federal regulation that addresses electronic records and signatures is important for medtech companies with FDA-regulated products. For these companies 21 CFR Part 11 impacts every document, process, and submission. Read our free regulatory brief for a background on the regulation and how medtech companies can achieve compliance.

More infoWatch ReplayGet the ebookGet the briefGet the case studyGet the data sheetGet the webinarGet the video
An overview of 21 CFR Part 11 regulations for medical device companies

Get the ebook

Get the case study

Get the webinar

Watch the replay!

Get the video

Get the data sheet

Thank you! Here's a link to your resource. We've also sent a copy to your inbox. Enjoy!
Thank you! We've sent you you details about accessing this event. If you do not receive an email in the next few minutes, please check your spam folder. Enjoy!
Download
Here's some additional content you may find helpful
 Introducing Rimsys Intel: A Free, Centralized Global Regulatory Intelligence Hub for Medtech
Introducing Rimsys Intel: A Free, Centralized Global Regulatory Intelligence Hub for Medtech
5 ways a RIM system can accelerate time-to-market for MedTech companies
5 ways a RIM system can accelerate time-to-market for MedTech companies
A primer on medical device classification
A primer on medical device classification
Here's your video, enjoy!
Check out these additional resources
A primer on medical device classification
A primer on medical device classification
Quick reference guide - global medical device UDI requirements and timelines
Quick reference guide - global medical device UDI requirements and timelines
 Introducing Rimsys Intel: A Free, Centralized Global Regulatory Intelligence Hub for Medtech
Introducing Rimsys Intel: A Free, Centralized Global Regulatory Intelligence Hub for Medtech
Oops! Something went wrong while submitting the form